<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Research COVID-19 Podcasts

Research Could Lead to New Therapeutic Options for Lymphedema Patients

‘It reminds me of times of war’: Tamara Terzian, PhD, also talks about the COVID-19 pandemic’s impact on her native France

Author Chris Casey | Publish Date April 2, 2020

Thanks to a somewhat unexpected research journey, Tamara Terzian, PhD, and her team recently uncovered a new molecular pathway to a previously untreatable and common lymphatic disease, lymphedema. Terzian explains how the establishment of a lymphatic club on the CU Anschutz Medical Campus – involving Beth Tamburini, PhD, assistant professor of medicine and immunology, and Traci Lyons, PhD, associate professor of medicine-medical oncology – helped to advance her team’s significant findings.

“This has been a very interesting journey of not only research, but of friendship and of collaboration on our campus,” she said. Read a story about the discoveries made in their lymphatic diseases study here

In this edition of the CU Anschutz 360 podcast, Terzian also shares thoughts on the COVID-19 pandemic’s impact on her native France.

Read a preprint article about the study here.